KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) EPS (Weighted Average and Diluted) (2016 - 2025)

Globus Medical (GMED) has disclosed EPS (Weighted Average and Diluted) for 15 consecutive years, with $1.02 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 436.84% year-over-year to $1.02, compared with a TTM value of $3.92 through Dec 2025, up 422.67%, and an annual FY2025 reading of $3.92, up 422.67% over the prior year.
  • EPS (Weighted Average and Diluted) was $1.02 for Q4 2025 at Globus Medical, up from $0.89 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.47 in Q2 2025 and bottomed at -$0.05 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.46, with a median of $0.45 recorded in 2021.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 3700.0% in 2024, while the deepest fall reached 110.42% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.14 in 2021, then soared by 250.0% to $0.49 in 2022, then crashed by 81.63% to $0.09 in 2023, then skyrocketed by 111.11% to $0.19 in 2024, then surged by 436.84% to $1.02 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GMED at $1.02 in Q4 2025, $0.89 in Q3 2025, and $1.47 in Q2 2025.